Single-dose colesevelam has no effect on postprandial GLP-1 levels, but increases CCK levels and decreases gallbladder refilling and gastric emptying in type 2 diabetes

E. Bahne, M. Hansen, D. P. Sonne, J. F. Rehfeld, J. J. Holst, T. Vilsboll, F. K. Knop

OriginalsprogEngelsk
Publikationsdatosep. 2015
Antal sider1
StatusUdgivet - sep. 2015

Citationsformater